Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Memantine Treatment Study of Pathological Gambling

Phase 2

Completed

Conditions: Pathological Gambling

Interventions: Drug: Memantine Hydrochloride

First Posted Date: 2008-01-03

Last Posted Date: 2013-04-08

Lead Sponsor: Yale University

Target Recruit Count: 29

Registration Number: NCT00585169

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
🇺🇸
University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, United States

Vascular Effects of Sertraline in Heart Failure

Terminated

Conditions: Heart Failure
Depression

Interventions: Drug: sertraline

First Posted Date: 2008-01-03

Last Posted Date: 2009-07-23

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT00585455

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse

Phase 1

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Prazosin Tablet
Drug: Placebo Tablet

First Posted Date: 2008-01-03

Last Posted Date: 2020-07-27

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT00585780

Locations: 🇺🇸
Yale University School of Medicine: Yale Stress Center, New Haven, Connecticut, United States

Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse

Phase 1

Completed

Conditions: Cocaine Dependent
Alcohol Dependent

Interventions: Drug: Placebo
Drug: Guanfacine

First Posted Date: 2008-01-03

Last Posted Date: 2016-11-30

Lead Sponsor: Yale University

Target Recruit Count: 75

Registration Number: NCT00585754

Locations: 🇺🇸
Yale University School of Medicine: Yale Stress Center, New Haven, Connecticut, United States

Modafinil, Sleep, and Cognition in Cocaine Dependence

Not Applicable

Completed

Conditions: Cocaine Dependence
Substance-induced Sleep Disorder
Substance-induced Cognitive Disorder

Interventions: Drug: Placebo
Drug: Modafinil

First Posted Date: 2007-12-28

Last Posted Date: 2012-09-14

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT00582491

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers

Not Applicable

Completed

Conditions: Cocaine-Related Disorder
Opiate Dependence

Interventions: Drug: Placebo
Drug: Disulfiram

First Posted Date: 2007-12-27

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 126

Registration Number: NCT00580827

Locations: 🇺🇸
West Haven VA, West Haven, Connecticut, United States

Do Treatments for Smoking Cessation Affect Alcohol Drinking?

Phase 2

Completed

Conditions: Alcohol Drinking

Interventions: Drug: varenicline
Drug: placebo

First Posted Date: 2007-12-27

Last Posted Date: 2018-02-07

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT00580645

Locations: 🇺🇸
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory, New Haven, Connecticut, United States

Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death

Completed

Conditions: Menopausal Women

First Posted Date: 2007-12-27

Last Posted Date: 2015-01-22

Lead Sponsor: Yale University

Target Recruit Count: 25

Registration Number: NCT00580775

Locations: 🇺🇸
Yale University School of Medicine / Yale New Haven Hospital, New Haven, Connecticut, United States

The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Phase 2

Completed

Conditions: Smoking Lapse Behavior

Interventions: Drug: bupropion
Drug: Placebo
Drug: varenicline

First Posted Date: 2007-12-27

Last Posted Date: 2018-02-08

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT00580853

Locations: 🇺🇸
Yale Center for Clinical Investigation, Yale University, New Haven, Connecticut, United States

Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes Mellitus

Completed

Conditions: Type 1 Diabetes
Hypoglycemia

First Posted Date: 2007-12-27

Last Posted Date: 2022-04-18

Lead Sponsor: Yale University

Target Recruit Count: 164

Registration Number: NCT00580710

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy